Han Liu
- Cancer Research top 1%
- MicroRNA in disease regulation 15
- Cancer-related molecular mechanisms research 14
- Molecular Biology top 1%
- Ubiquitin and proteasome pathways 24
- RNA modifications and cancer 20
- Epigenetics and DNA Methylation 13
- CRISPR and Genetic Engineering 12
- Pluripotent Stem Cells Research 12
- Oncology top 2%
- Cell Biology top 1%
- Neurology top 5%
-
- Autophagy in Disease and Therapy 15
- Co-authors
- Michael J. ClagueSylvie UrbéRulang JiangYu LanQingyong MaDaniel J. RigdenErxi WuJudy M. Coulson
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Han Liu
327 papers receiving 9.2k citations
Peers
Comparison fields: 5 of 185
- Cancer Research 1.4k
- Molecular Biology 5.0k
- Oncology 1.5k
- Cell Biology 789
- Neurology 279
Countries citing papers authored by Han Liu
This map shows the geographic impact of Han Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Liu more than expected).
Fields of papers citing papers by Han Liu
This network shows the impact of papers produced by Han Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Liu. The network helps show where Han Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Han Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 11 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 6 | |
| 8 | 2022 | 17 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 11 | |
| 11 | 2020 | 9 | |
| 12 | 2020 | 40 | |
| 13 | 2020 | 30 | |
| 14 | 2015 | 20 | |
| 15 | 2014 | 131 | |
| 16 | 2014 | 156 | |
| 17 | 2013 | 267 | |
| 18 | 2013 | 86 | |
| 19 | Invasive cribriform carcinoma in a Chinese population: comparison with low-grade invasive ductal carcinoma-not otherwise specified. | 2013 | 21 |
| 20 | 2008 | 90 |
About Han Liu
Han Liu is a scholar working on Molecular Biology, Cancer Research, Cell Biology, Oncology and Leadership and Management, having authored 350 papers that have together received 9.3k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (24 papers), RNA modifications and cancer (20 papers), MicroRNA in disease regulation (15 papers), Autophagy in Disease and Therapy (15 papers), Cancer-related molecular mechanisms research (14 papers), Epigenetics and DNA Methylation (13 papers), CRISPR and Genetic Engineering (12 papers) and Pluripotent Stem Cells Research (12 papers). The work is most often cited by research in Cancer Research (1.4k citations), Molecular Biology (5.0k citations), Oncology (1.5k citations), Cell Biology (789 citations) and Neurology (279 citations). Han Liu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Michael J. Clague, Sylvie Urbé, Rulang Jiang, Yu Lan, Qingyong Ma, Daniel J. Rigden, Erxi Wu, Judy M. Coulson, Qinhong Xu and Igor Barsukov. Their work appears in journals such as Stem Cell Research, PLoS ONE, Scientific Reports, Developmental Biology and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.